Fundamentals of Acquired Immunity - PowerPoint PPT Presentation

1 / 96
About This Presentation
Title:

Fundamentals of Acquired Immunity

Description:

Fundamentals of Acquired Immunity I. Definitions Immunology the study of all aspects of host defense against infection and of adverse consequences of immune ... – PowerPoint PPT presentation

Number of Views:133
Avg rating:3.0/5.0
Slides: 97
Provided by: pagesCabr
Category:

less

Transcript and Presenter's Notes

Title: Fundamentals of Acquired Immunity


1
Fundamentals of Acquired Immunity
2
  • I. Definitions

3
  • Immunology the study of all aspects of host
    defense against infection and of adverse
    consequences of immune response
  • Immunity the state of protection fro infectious
    diseases utilizing both innate and acquired
    mechanisms

4
  • Immune response - a specific and complex series
    of events throughout the animals body that helps
    it defend against disease-causing organisms or
    substances
  • Antigen particular foreign molecules that
    stimulate and immune response
  • Often immunogenic on its own, otherwise requires
    a carrier molecule)
  • Non-self substances to which lymphocytes can
    respond

5
  • Innate Immunity non-specific protective
    mechanisms conferring basic resistance to disease

6
  • general, physical, chemical, and biological
    barriers against disease
  • discussed in previous unit
  • also referred to as innate or natural immunity

7
II. Different Types of Acquired Immunity
8
  • Acquired Immunity specific protective
    mechanisms displaying specificity, diversity,
    memory and self/non-self discrimination
  • Often dependent on innate immunity for full
    activation
  • Can be acquired actively or passively

9
  • Naturally acquired active immunity - An
    individual comes in contact with an antigen (Ag)
    and produces sensitized lymphocytes and/or
    antibodies that inactivate the antigen
  • Ag is encountered naturally
  • Immune responses are activated
  • Antibodies made
  • Lymphocytes sensitized
  • Result Ag inactivated or destroyed
  • Memory generated (long-lasting immunity)

10
  • Naturally acquired passive immunity - transfer of
    antibodies (Abs) from one individual to another
  • Abs transferred from a donor to a recipient
    (adoptive transfer)
  • Maternal transfer of IgG Abs to fetus across the
    placenta
  • Maternal transfer of IgA Abs to newborn in
    colostrom and breast milk
  • Newborn has immunity to infections encountered by
    mother previously
  • Short-lived (weeks to months)

11
  • Artificially acquired active immunity -
    deliberate exposure of an individual to a vaccine
    with subsequent development of an immune response
  • Vaccine preparation of attenuated or killed
    microbes or inactivated toxins (toxoids)

12
  • Artificially acquired passive immunity -
    deliberate introduction of antibodies into an
    individual
  • Abs made deliberately in another animal or
    synthesized using in vitro methods
  • Antiserum
  • Antitoxins
  • Antivenom
  • Monoclonal antibodies (in vitro)

13
  • III. Origin, Maturation and Function of
    Lymphocytes

14
B Lymphocytes
  • Birds Bursa of fabricius
  • Part of the chicken cloaca where B cells mature
  • Absent in mammals
  • Humans
  • Fetal liver
  • Bone marrow stem cells
  • Two types
  • T-dependent B cells (require T cell help)
  • T-independent B cells (do not require T cell help)

15
T Lymphocytes
  • Originate in the thymus
  • DiGeorge Syndrome athymic no T cells
  • Specialized anatomicl locations responsible for
    educating T cells
  • Cortex
  • Medulla
  • Education involves two main processes
  • Positive selection
  • Negative selection

16
  • Three types
  • TH1 Inflammatory T cells
  • Help macrophages (and B cells)
  • TH2 Helper T cells
  • Help B cells
  • Tcyt Cytotoxic T cells (killer T cells)
  • Kill target cells using perforin and granzyme

17
Natural Killer Cells (NK cells)
  • Probably derived from prethymic lymphocytes
  • Do not have the characteristics of either B-cells
    or T-cells
  • AKA Large Granular Lymphocytes (LGL)
  • AKA Null cells
  • Not equivalent to killer T cells but kill their
    target cells using same mechanism (perforin and
    granzyme)
  • Participate in ADCC

18
  • Humoral Immunity

19
B Cells and Their Role in Humoral Immunity
  • Involvement of Ab in immune responses
  • T-dependent
  • T-independent
  • Protects against pathogens that exist in fluid
    spaces
  • Bacteria and their toxins
  • Viruses
  • Protozoans
  • Helminths
  • When B cells begin to produce antibody upon
    activation by antigen, they differentiate into
    plasma cells

20
Cell-Mediated Immunity
21
T Cells and Their Role in Cell-Mediated Immunity
  • Involvement of T cells subsets
  • TH1
  • TH2
  • Tcyt
  • Requirement for direct interaction with infected
    cell or foreign cells
  • Involves complex of T cell receptor (TCR), Major
    Histocompatibility Complex molecule (MHC) and
    Antigenic peptide fragment

22
  • Functions
  • Lysis of host cells infected by viruses
  • Elimination of cancer cells
  • Productin of cytokines to assist other cells in
    eradicating foreign Ags
  • Cytokines Molecules secreted by one cell and
    affecting a different cell type ? specific
    regulatory interactions
  • Trasplantation rejection
  • Due to differences in MHC class I and class II
    molecules (alloantigens)

23
NK Cells and Their Role in Cell-Mediated Immunity
  • Nonspecifically kill tumor cells, virus-infected
    cells, and other parasite-infected cells
  • Play a role in regulating the immune response
  • Exhibit antibody dependent cell-mediated
    cytotoxicity (ADCC)

24
Figure 31.20
25
  • IV. The Nature of Antigens

26
SELF VERSUS FOREIGN
27
Self
  • Prior to and after birth, the immune system
    develops and is able to differentiate between
    self proteins and foreign proteins
  • T cells that are responsive to self Ags are
    eliminated early in their developmental pathway
  • Negative selection
  • Apoptosis occurs in the thymus
  • Never enter periphery

28
  • B cells interacting with self Ags either apoptose
    or anergize
  • Apoptosis programmed cell death
  • Anergy induction of non-responsive state

29
Self-Tolerance
  • The process of elimination of self-reactive
    lymphocytes is called self tolerance
  • Leads to removal of what could initiate harmful
    autoreactive response Autoimmunity
  • Is very efficient, but not complete

30
FOREIGN
31
Immunogenicity
  • The term immunogen is often used synonymously
    with the term antigen
  • Careful!!!!
  • All immunogens are antigens, but not all antigens
    are immunogens
  • An immunogen is any substance that can mediate an
    immune response

32
  • Types of Antigens (immunogens)
  • Antigens recognized by B cells
  • Proteins, peptides, glycoproteins,
    nucleoproteins, polysaccharides, lipids,
    glycolipids, and small chemical groups (haptens)
  • B cell receptor Antibody (Ab)
  • Antigens recognized by T cells
  • Peptide in association with MHC molecule
  • T cell receptor TCR

33
Epitopes
  • Epitopes (antigenic determinant sites) are areas
    of an antigen that can stimulate production of
    specific antibodies and that can combine with
    them
  • Some antigens have more than one site capable of
    interacting with Abs

34
  • Valence - the number of epitopes on an antigen
    determines number of antibody molecules an
    antigen can combine with at one time
  • Generally the high the valency, the more
    immunogenic the substance
  • Epitopes (determinants) that are more easily
    accessible stimulate better immune response
    (projections or NH2/COOH ends)

35
Figure 32.3 The number of antigenic determinant
sites (epitopes) on an antigen is its valence.
36
  • Hapten - a small organic molecule that is not
    itself antigenic but that may become antigenic
    when bound to a larger carrier molecule
  • Examples
  • Dinitrophenol (DNP)
  • Penicillin

37
Figure 32.4 Effect of carrier on immunogenicity
of hapten.
38
  • V. Structure and Function of Antibodies
    (Immunoglobulins)

39
  • What is an antibody?

40
Antibodies
  • A group of glycoproteins in the blood, serum, and
    tissue fluids of mammals
  • Produced in response to an antigen and can
    combine specifically with that antigen
  • In the serum, four major classes can be measured
    electrophoretically, but there are actually five
    classes

41
Figure 32.6 Electrophoresis of human serum
showing distribution of serum proteins and four
major classes of immunoglobulins.
42
  • Immunoglobulin structure
  • Multiple antigen-combining sites (usually two
    some can form multimeric antibodies with up to
    ten combining sites)
  • Composed of four polypeptide chains (two heavy or
    long, and two light or short) that form a
    flexible Y with a hinge region
  • Heavy chain 440 aa, 50-70kDal (GAMED)
  • Light chain 220 aa, 25kDal (kappa or lambda)

43
  • The stalk of the Y (called the Fc) is constant in
    amino acid sequence (i.e., the amino acid
    sequences of antibodies of the same subclass do
    not vary significantly)
  • Constant regions are relatively invariable
    between Igs belonging to the same class (
    isotype, IgG, IgA, IgM, IgE, IgD)
  • Constant regions confer different biological
    properties upon the Ig classes (in vivo half
    life, anatomical location, interactions with
    other molecules)

44
  • B cells can switch from production of one type of
    Ig to another type (isotype) by a mechanism known
    as ISOTYPE SWITCHING
  • Isotype switching is mediated by signals received
    during ongoing immune responses (e.g. T cell
    cytokines)

45
  • The arms of the Y have variable regions and
    constitute the antigen-binding domains (Fab)
  • Each Ab has 2 Ag-combining sites (bivalent) made
    up of H and L chain regions encoded by the
    variable portion of the Ig (VLVH)
  • Some Abs exist as dimers (IgA) or pentamers (IgM)
    and so have 4 or 10 Ag-binding sites, respectively

46
  • Intrachain disulfide bonds create loops on both
    heavy and light chain
  • Each loop contains 25 aa making up a single
    domain
  • Interchain disulfide bonds hold the heavy and
    light chains together
  • H to H
  • H to L

47
  • Within the Fab segment are hypervariable (or
    complementarity determining) regions
  • these regions are responsible for the diversity
    of antibodies

48
Figure 32.8 Constant and Variable Domains in
Heavy and Light Chains Dark blue
hypervariable regions in the variable
domains Hypervariable regions are also known as
complementarity determining regions (CDRs).
49
Pockets Grooves Extended Surfaces Peptide Ag
Red HIV peptide Orange HEL F(ab) frag. 5
CDRs used Red Ab contact sites Blue
Backbone Yellow Ag
50
  • There are five types of heavy chains that
    determine the five classes (isotypes) of
    immunoglobulins (IgG, IgA, IgM, IgD, and IgE)
  • In IgG there are four subclasses, and in IgA
    there are two subclasses

51
  • Categories of immunoglobulin types
  • Isotypes - variations in the constant regions of
    heavy chains that are associated with different
    classes and subclasses
  • Allotypes - genetically controlled allelic forms
    of the immunoglobulin molecule
  • Idiotypes - individual-specific immunoglobulin
    molecules that differ in the hypervariable
    regions of the Fab segments

52
  • Review of Immunoglobulin Function
  • Fab region binds to antigen
  • Fc region mediates binding to host tissue, to
    various cells of the immune system, to some
    phagocytic cells, or to the first component of
    the complement system

53
  • Binding of antibody to an antigen does not
    destroy the antigen, but marks (targets) the
    antigen for immunological attack or attack by the
    nonspecific defense mechanisms that do destroy it
  • Opsonization - coating a bacterium with
    antibodies to stimulate phagocytosis

54
Figure 31.15
55
  • Immunoglobulin classes (Isotypes)
  • IgG - monomeric protein, 70 to 75 of Ig pool
  • Antibacterial and antiviral
  • Enhances opsonization
  • Neutralizes toxins
  • Only IgG is able to cross placenta (naturally
    acquired passive immunity for newborn)

56
  • Activates the complement system by the classical
    pathway
  • Four subclasses with some differences in function
  • IgG1
  • IgG2
  • IgG3
  • IgG4

57
  • IgM - pentameric protein, 10 of Ig pool
  • First antibody made during B-cell maturation
  • First antibody secreted into serum during primary
    antibody response
  • Never leaves the bloodstream
  • Activates complement by classical pathway
  • Enhances phagocytosis of target cells

58
  • Agglutinates bacteria and foreign red blood cells
  • Up to 5 may be hexameric which is better able to
    activate the complement system than pentameric IgM

59
Figure 32.11
60
  • IgA - dimeric protein, 15 of Ig pool
  • Associated with secretory mucosal surfaces
  • Protects gastrointestinal tract, respiratory
    tract, and genitourinary tract
  • Also found in saliva, tears, and breast milk
    (protects nursing newborns)
  • Secretory form (sIgA) helps rid the body of
    antibody-antigen complexes by excretion into the
    gut lumen and subsequent excretion from the body
  • Adherence Inhibition

61
Figure 32.12
62
  • IgD - monomeric protein, trace amounts in serum
  • Abundant on surface of B cells
  • May play a role in B-cell recognition of antigens
  • May play a role in B cell anergy
  • Does not activate the complement system
  • Cannot cross the placenta

63
Figure 32.13
64
  • IgE - monomeric protein, less than 1 of Ig pool
  • Skin-sensitizing and anaphylactic antibodies
  • When an antigen cross-links two molecules of IgE
    on the surface of a mast cell or basophil, it
    triggers release of histamine, and it increases
    intestinal motility, which helps to eliminate
    helminthic parasites

65
Figure 32.14
66
  • Diversity of Antibodies

67
  • A number of mechanisms contribute to the
    generation of antibody diversity
  • Somatic recombination (gene shuffling)
  • Combinatorial joining (unique H and L chains)
  • Somatic Hypermutation
  • Isotype switching

68
  • Somatic Recombination
  • Ig genes contain multiple segments of variable
    encoding regions of heavy and light chains (VDJ
    for heavy VJ for light)
  • During differentiation of B cells, these genes
    are rearranged on the chromosome to form various
    combinations
  • The number of different antibodies possible is
    the product of the number of light chains
    possible and the number of heavy chains possible

69
  • Imprecise joining - during combinations, the same
    segments can be joined at different nucleotides,
    thus increasing the number of codons and the
    possible diversity (N and P nucleotides)
  • Somatic mutations - the V regions of germ-line
    DNA are susceptible to a high rate of somatic
    mutation following B cell activation
  • The total diversity produces more than 2x108
    different antibody molecules

70
Fig. 32.15
71
Figure 32.16
72
Figure 32.17
73
  • Specificity of Antibodies

74
  • The Clonal Selection Theory

75
  • Because of somatic recombination, combinatorial
    joining and somatic mutation, there are a small
    number of B cells capable of responding to any
    given antigen

76
  • Each group of cells is derived asexually from a
    parent cell and is referred to as a clone
  • There is a large, diverse population of B-cell
    clones that collectively are capable of
    responding to many possible antigen
  • The surface receptor molecules of the B cells
    bind to the appropriate antigen

77
  • The cell is then stimulated to divide and
    differentiate into two populations of cells
  • Plasma cells
  • Memory cells
  • Plasma cells are protein factories that produce
    about 2,000 antibodies per second for their brief
    life span (5-7 days)

78
Figure 32.18
79
  • Memory cells, like the original B cells, can
    differentiate into plasma cells if they are
    stimulated by being bound to the antigen
  • because there are more memory cells than original
    B cells, the secondary (anamnestic) response can
    be (and usually is) faster and larger than the
    primary response
  • they have long life spans (years or decades)

80
  • Sources of Antibodies (pure homogeneous
    preparations)

81
  • Immunization

82
  • Procedure
  • Inject animal with antigen to stimulate primary
    immune response
  • Initial lag phase of several days
  • Log phase antibody titer rises logarithmically
  • Plateau phase antibody titer stabilizes
  • Decline phase antibody titer decreases because
    the antibodies are metabolized or cleared from
    the circulation
  • Mostly IgM low-affinity antibodies

83
Fig. 32.19
84
  • After a period of time, give animal a series of
    booster injections with same antigen to stimulate
    secondary immune response, or anamnestic response
  • Shorter lag phase, higher antibody titer
  • Mostly IgG high-affinity antibodies (affinity
    maturation)
  • Withdraw blood from animal allow it to clot and
    remove fluid (serum), which is referred to as
    antiserum since it is from a specifically
    immunized host

85
Fig. 32.19
86
  • Limitations
  • This method results in polyclonal antibodies
    which have different epitope specificities thus
    sensitivity is lower, and the antibodies often
    cross-react with closely related antigens
  • Repeated injections with antiserum from one
    species into another can cause serious allergic
    reactions
  • Antiserum contains a mixture of antibodies, not
    all of which are of interest

87
  • Hybridomas - overcome some of the limitations of
    antisera
  • Inject animals with antigen
  • Separate spleen cells (which contain plasma
    cells)
  • Fuse spleen cells with myeloma cells (tumor cells
    of the immune system that produce large
    quantities of antibodies and that are easy to
    culture)

88
  • Culture fused cells (hybridomas) so that each
    grows into a separate colony
  • Some plasma cells that fused with a myeloma cell
    will produce the desired antibody
  • Screen colonies for those producing desired
    antibody

89
  • Can grow many desired colonies to obtain large
    amounts of antibody
  • Antibodies produced by this method are monoclonal
    (react with only one epitope) since they come
    from the fusion of a single plasma cell with the
    tumor cell

90
Figure 32.20
91
  • Have a variety of uses in which high specificity
    is required
  • Tissue typing for transplants
  • Identification and epidemiological study of
    infectious microorganisms
  • Identification of tumor and other surface antigens

92
  • Classification of leukemias and T-cell
    populations
  • Sensitive diagnostic procedures
  • Immunotoxins - used in the targeted delivery of a
    toxic substance to a particular cell type
    chemotherapeutic agents

93
Box 32.1
94
  • Catalytic Antibodies

95
  • They are monoclonal antibodies made by subjecting
    an animal to an enzyme-substrate transition-state
    analogue and then producing a hybridoma
  • The binding pocket on the antibody lowers the
    energy of activation of a reaction by ensuring
    the proper orientation of the reactant(s)

96
  • Currently, catalytic antibodies have been
    produced that can transform relatively simple
    compounds, but the potential is great if
    antibodies that act on proteins and nucleic acids
    can be produced
Write a Comment
User Comments (0)
About PowerShow.com